This is a medical procedure where healthy bone marrow is transferred into a patient's body. This is often done to treat certain types of cancer or blood disorders, replacing the patient's own diseased marrow.
Every report comes from a Lived member, sent anonymously.
Have you had Bone Marrow Transplantation for AML (Acute Myeloid Leukemia)?
A bone marrow transplant replaces blood-forming stem cells that are diseased, failing or destroyed by treatment with healthy ones. These stem cells live in the bone marrow, the spongy tissue inside bones such as the hips, and they produce red blood cells, infection-fighting white blood cells and platelets that help blood clot. Once infused, the new cells travel to the marrow and begin making blood again. Despite the name, most transplants today use stem cells collected from the bloodstream rather than from the marrow itself, so doctors often call it a stem cell transplant. Transplants are used most often for blood cancers such as leukemia, lymphoma, multiple myeloma and myelodysplastic syndromes, and sometimes for certain other cancers, including some childhood tumors and testicular cancer. They are also used for conditions in which the marrow cannot make healthy cells, such as severe aplastic anemia, sickle cell disease, thalassemia and some inherited immune deficiencies. There are two main types. In an autologous transplant, a person's own stem cells are collected and frozen, then returned after very high doses of chemotherapy. This lets doctors use doses that would otherwise permanently wipe out the marrow. In an allogeneic transplant, the cells come from a donor. Donors are matched using HLA (human leukocyte antigen) typing, a blood test of markers on cells that help the immune system tell self from non-self. A brother or sister is the most likely full match, but unrelated volunteers from national registries, half-matched relatives and umbilical cord blood are also used. Donor cells can attack leftover cancer cells, an extra benefit called the graft-versus-tumor effect. A transplant is considered when it offers a better chance of cure or longer survival than other treatment. Whether it makes sense depends on the disease and its stage, how well other treatments are likely to work, whether a suitable donor is available, and the person's age and overall health. Lower-dose "reduced-intensity" (or "mini") transplants have made the procedure possible for many older people and those with other health problems.
Preparation usually takes weeks to months. Testing checks the heart, lungs, kidneys, liver, teeth and infections, and confirms that the disease is in a state where a transplant is likely to help. For an allogeneic transplant, the search for and testing of a donor happens in parallel. For an autologous transplant, a person's own stem cells are collected ahead of time, usually after several days of injections that move stem cells from the marrow into the blood, where a machine filters them out. Most people have a central venous catheter placed: a thin tube in a large vein of the chest, neck or arm that stays in for weeks or months. It is used for the stem cell infusion, medicines, fluids, transfusions, nutrition and blood draws, so frequent needle sticks are not needed. The last step before the infusion is conditioning, a course of high-dose chemotherapy, sometimes with radiation, usually over a week or two. Conditioning destroys diseased cells, makes room in the marrow, and in allogeneic transplants suppresses the immune system so it does not reject the donor cells. Myeloablative conditioning uses the highest doses; reduced-intensity conditioning uses lower doses and relies more on the donor cells to control the disease. The practical planning matters as much as the medical work-up. Transplant centers ask people to choose a caregiver early, an adult who can be with them all day, every day for roughly the first one to three months, attend appointments, manage medicines and provide transportation. People who live far from the center often need housing nearby, and planning usually includes medical leave from work, insurance approval, child and pet care, and an advance directive. Because conditioning can cause infertility, this is also the time to ask about preserving fertility. Many centers offer meetings with a social worker or counselor, since the process is long and emotionally demanding for the whole family.
The transplant itself is often quieter than people expect. On the day of infusion, often called day zero, the stem cells are given through the central catheter in much the same way as a blood transfusion. The recipient is awake, and medicine may be given beforehand to prevent reactions or help with relaxation. Infusion usually takes from about one to five hours, depending on the volume of cells. Some people notice a strange taste or smell from the preservative used to freeze the cells, and some have chills, fever, flushing, nausea, hives, headache or a drop in blood pressure during or soon after the infusion. The team monitors vital signs throughout and treats these reactions as they arise. When a donor gives cells from the bloodstream, the collection is done through an IV over a few hours, similar to a long blood donation. When bone marrow is collected directly, the donor receives general anesthesia while marrow is drawn from the back of the hip bones. That anesthesia applies to the donor, not to the person receiving the transplant.
The weeks after the infusion are spent waiting for engraftment, when the new cells settle in the marrow and blood counts start to rise. This usually happens within the first six weeks, and counts recover more slowly after a cord blood transplant. Until then, the body has very few white blood cells to fight infection and few platelets to stop bleeding. Many people stay in a specialized transplant unit, although some centers manage part of the process as outpatient care nearby. During this time, people commonly receive red blood cell and platelet transfusions, antibiotics and antiviral and antifungal medicines to prevent infection, and, after an allogeneic transplant, medicines to prevent graft-versus-host disease. Painful mouth and throat sores, nausea and diarrhea from conditioning can make eating difficult, so nutrition is sometimes given through the vein for a while. After discharge, follow-up is frequent: often two or three clinic visits a week at first for blood tests, transfusions or fluids. People who travel for an allogeneic transplant are often asked to stay near the center for about the first 100 days. Fatigue and poor appetite are common, and it can take up to a year to feel like oneself again. Walking and gradually increasing activity help rebuild strength. The immune system recovers much more slowly than blood counts: several months after an autologous transplant and one to two years after an allogeneic one. During that time, everyday habits lower infection risk. These include frequent handwashing, avoiding crowds and people who are sick, careful food safety (no raw or undercooked meat, fish or eggs), avoiding gardening and soil, and letting someone else clean a cat's litter box. Good mouth care and sun protection also matter, especially after an allogeneic transplant. The transplant wipes out the protection from childhood vaccines, so the team provides a schedule for getting them again. Call the transplant team right away for a temperature of 100.5°F (38°C) or higher, chills or sweats. A fever can be the first or only sign of an infection that becomes life threatening, and fever-reducing medicine should not be taken first without the team's advice because it can hide a fever. Also call promptly for redness, swelling or drainage where the catheter enters the skin; a new rash or blisters; diarrhea that will not stop or is bloody; yellowing of the skin or eyes; a worsening cough or shortness of breath with light activity or at rest; inability to eat or drink; or a severe or persistent headache.
A bone marrow transplant is one of the most demanding treatments in medicine, and some complications can be life threatening. The risk depends heavily on the type of transplant, the conditioning intensity, how closely a donor matches, the disease being treated, and the person's age and health. Autologous transplants generally carry lower early risk than allogeneic ones. Infection is the most common serious danger, both in the weeks before engraftment and during the long period of immune recovery. Bleeding can occur while platelet counts are low. Conditioning can also cause hair loss, mouth sores, fatigue and, less often, damage to the liver, lungs, kidneys or heart, including a blockage of the small veins in the liver. Graft-versus-host disease (GVHD) is specific to allogeneic transplants. It happens when donor immune cells see the recipient's body as foreign and attack it, most often the skin, liver and gut. Acute GVHD, which usually starts in the first few months, may cause rash, diarrhea or jaundice. Chronic GVHD usually starts more than three months after transplant, can last for years, and may cause dry eyes and mouth, skin tightening, joint stiffness or lung problems. It is treated with steroids and other immune-suppressing medicines, which themselves raise infection risk. A closer donor match lowers the risk, and the same donor immune cells that cause GVHD also help fight remaining cancer, which is part of the trade-off. The graft may fail to take or may be rejected, which is uncommon but serious and may require another transplant. After an autologous transplant, there is a small chance that cancer cells are returned with the collected cells, and the original disease can come back after either type. Long-term effects can include infertility or early menopause, cataracts, thyroid and other hormone changes, bone and muscle weakness, organ damage, delayed growth in children, and a higher risk of new cancers years later. For this reason, survivors need lifelong follow-up, including regular checks of the skin, mouth, eyes, heart and bones. Transplants are also very costly and can involve months away from work and home, so the financial and caregiving burden is part of the decision.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Bone Marrow Transplantation, what to expect, or ask the community a question.